| UniProt ID | XPR1_HUMAN | |
|---|---|---|
| UniProt AC | Q9UBH6 | |
| Protein Name | Xenotropic and polytropic retrovirus receptor 1 | |
| Gene Name | XPR1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 696 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein . |
|
| Protein Description | Plays a role in phosphate homeostasis. Mediates phosphate export from the cell. [PubMed: 23791524] | |
| Protein Sequence | MKFAEHLSAHITPEWRKQYIQYEAFKDMLYSAQDQAPSVEVTDEDTVKRYFAKFEEKFFQTCEKELAKINTFYSEKLAEAQRRFATLQNELQSSLDAQKESTGVTTLRQRRKPVFHLSHEERVQHRNIKDLKLAFSEFYLSLILLQNYQNLNFTGFRKILKKHDKILETSRGADWRVAHVEVAPFYTCKKINQLISETEAVVTNELEDGDRQKAMKRLRVPPLGAAQPAPAWTTFRVGLFCGIFIVLNITLVLAAVFKLETDRSIWPLIRIYRGGFLLIEFLFLLGINTYGWRQAGVNHVLIFELNPRSNLSHQHLFEIAGFLGILWCLSLLACFFAPISVIPTYVYPLALYGFMVFFLINPTKTFYYKSRFWLLKLLFRVFTAPFHKVGFADFWLADQLNSLSVILMDLEYMICFYSLELKWDESKGLLPNNSEESGICHKYTYGVRAIVQCIPAWLRFIQCLRRYRDTKRAFPHLVNAGKYSTTFFMVTFAALYSTHKERGHSDTMVFFYLWIVFYIISSCYTLIWDLKMDWGLFDKNAGENTFLREEIVYPQKAYYYCAIIEDVILRFAWTIQISITSTTLLPHSGDIIATVFAPLEVFRRFVWNFFRLENEHLNNCGEFRAVRDISVAPLNADDQTLLEQMMDQDDGVRNRQKNRSWKYNQSISLRRPRLASQSKARDTKVLIEDTDDEANT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 48 (in isoform 2) | Ubiquitination | - | 43.40 | 21890473 | |
| 48 (in isoform 1) | Ubiquitination | - | 43.40 | 21890473 | |
| 48 | Ubiquitination | VTDEDTVKRYFAKFE CCCHHHHHHHHHHHH | 43.40 | 21906983 | |
| 50 | Phosphorylation | DEDTVKRYFAKFEEK CHHHHHHHHHHHHHH | 11.37 | 18212344 | |
| 57 | Ubiquitination | YFAKFEEKFFQTCEK HHHHHHHHHHHHHHH | 44.26 | - | |
| 64 | Ubiquitination | KFFQTCEKELAKINT HHHHHHHHHHHHHHH | 61.24 | - | |
| 76 (in isoform 2) | Ubiquitination | - | 47.24 | 21890473 | |
| 76 (in isoform 1) | Ubiquitination | - | 47.24 | 21890473 | |
| 76 | Ubiquitination | INTFYSEKLAEAQRR HHHHHHHHHHHHHHH | 47.24 | 21906983 | |
| 99 | Ubiquitination | QSSLDAQKESTGVTT HHHHHHHHHHHCCCH | 56.18 | - | |
| 99 (in isoform 2) | Ubiquitination | - | 56.18 | - | |
| 102 | Phosphorylation | LDAQKESTGVTTLRQ HHHHHHHHCCCHHHH | 36.44 | 29255136 | |
| 105 | Phosphorylation | QKESTGVTTLRQRRK HHHHHCCCHHHHHCC | 22.81 | 29255136 | |
| 106 | Phosphorylation | KESTGVTTLRQRRKP HHHHCCCHHHHHCCC | 19.96 | 29255136 | |
| 162 | Ubiquitination | GFRKILKKHDKILET CHHHHHHHCHHHHHH | 54.30 | - | |
| 165 | Ubiquitination | KILKKHDKILETSRG HHHHHCHHHHHHCCC | 49.24 | - | |
| 273 | Methylation | WPLIRIYRGGFLLIE HHHHHHHHCCCHHHH | 36.07 | 24377067 | |
| 273 | Dimethylation | WPLIRIYRGGFLLIE HHHHHHHHCCCHHHH | 36.07 | - | |
| 474 (in isoform 2) | Ubiquitination | - | 4.56 | - | |
| 483 | Phosphorylation | HLVNAGKYSTTFFMV HHHHCCCCCCHHHHH | 15.44 | - | |
| 498 | Phosphorylation | TFAALYSTHKERGHS HHHHHHHHHHHCCCC | 24.34 | - | |
| 539 | Ubiquitination | MDWGLFDKNAGENTF CCCCCCCCCCCCCCE | 41.17 | - | |
| 574 | Phosphorylation | VILRFAWTIQISITS HHHHHHEEEEEEEEE | 10.28 | - | |
| 594 | Phosphorylation | HSGDIIATVFAPLEV CCCCEEEEEECCHHH | 13.02 | - | |
| 597 (in isoform 2) | Ubiquitination | - | 11.93 | 21890473 | |
| 619 (in isoform 2) | Ubiquitination | - | 41.34 | 21890473 | |
| 660 | Phosphorylation | RNRQKNRSWKYNQSI HHHHHHHCCCCCCCC | 37.00 | 19581576 | |
| 662 | Ubiquitination | RQKNRSWKYNQSISL HHHHHCCCCCCCCCC | 35.25 | 21890473 | |
| 662 (in isoform 1) | Ubiquitination | - | 35.25 | 21890473 | |
| 663 | Phosphorylation | QKNRSWKYNQSISLR HHHHCCCCCCCCCCC | 16.51 | 22167270 | |
| 666 | Phosphorylation | RSWKYNQSISLRRPR HCCCCCCCCCCCCCC | 15.54 | 22167270 | |
| 668 | Phosphorylation | WKYNQSISLRRPRLA CCCCCCCCCCCCCHH | 22.52 | 22167270 | |
| 676 | Phosphorylation | LRRPRLASQSKARDT CCCCCHHCCCCCCCC | 39.31 | 26074081 | |
| 678 | Phosphorylation | RPRLASQSKARDTKV CCCHHCCCCCCCCEE | 26.28 | 26074081 | |
| 684 | Ubiquitination | QSKARDTKVLIEDTD CCCCCCCEEEEECCC | 39.06 | 2190698 | |
| 684 (in isoform 1) | Ubiquitination | - | 39.06 | 21890473 | |
| 690 | Phosphorylation | TKVLIEDTDDEANT- CEEEEECCCCCCCC- | 32.34 | 30266825 | |
| 696 | Phosphorylation | DTDDEANT------- CCCCCCCC------- | 47.22 | 30266825 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of XPR1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of XPR1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of XPR1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| KDIS_HUMAN | KIDINS220 | physical | 28514442 | |
| B3A2_HUMAN | SLC4A2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 616413 | Basal ganglia calcification, idiopathic, 6 (IBGC6) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-668 AND THR-690, ANDMASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666; SER-668 ANDTHR-690, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-690, AND MASSSPECTROMETRY. | |